Literature DB >> 23086529

Ln(3+)-doped nanoparticles for upconversion and magnetic resonance imaging: some critical notes on recent progress and some aspects to be considered.

Frank C J M van Veggel1, Cunhai Dong, Noah J J Johnson, Jothirmayanantham Pichaandi.   

Abstract

In this feature article we will critically discuss the synthesis and characterisation aspects of Ln(3+)-doped nanoparticles (NPs) that show upconversion, upon 980 nm excitation. Upconversion is a non-linear process that converts two or more low-energy photons, often near-infrared photons, into one of higher energy, e.g. blue and 800 nm from Tm(3+) and green and red from Er(3+) or Ho(3+). Nearly all researchers use the absorption of 980 nm light by Yb(3+) as the sensitiser for the co-doped emissive Ln(3+) ions. The focus will be on LnF(3) and MLnF(4) (M = alkali metal) as the host matrix, because most progress has been made with these. In particular we will argue that a detailed understanding of how the dopant ions and the host Ln(3+) ions are distributed (in the core) and how (doped) shell growth occurs is not well understood. Moreover, their use as optical and magnetic resonance imaging contrast agents will be discussed. We will argue that deep-tissue imaging beyond 600 μm with retention of optical resolution, i.e. to see fine structure such as blood capillaries in brain tissues, has not yet been achieved. Three key parameters have been identified as impediments: (i) the low absorption efficiency of the Yb(3+) sensitiser, (ii) the low quantum yield of upconversion, and (iii) the long-lived excited states. On the other hand, there are very encouraging results that suggest that these nanoparticles could be developed into very potent magnetic resonance imaging (MRI) contrast agents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23086529     DOI: 10.1039/c2nr32124f

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  2 in total

1.  Multifunctional yolk-in-shell nanoparticles for pH-triggered drug release and imaging.

Authors:  Hongyu Chen; Bin Qi; Thomas Moore; Fenglin Wang; Daniel C Colvin; Liurukara D Sanjeewa; John C Gore; Shiou-Jyh Hwu; O Thompson Mefford; Frank Alexis; Jeffrey N Anker
Journal:  Small       Date:  2014-04-19       Impact factor: 13.281

2.  Solvothermal synthesis and modification of NaYF4:Yb/Er@NaLuF4:Yb for enhanced up-conversion luminescence for bioimaging.

Authors:  Hua Li; Xuguang Liu; Xia Li
Journal:  RSC Adv       Date:  2019-12-19       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.